Stocks and InvestingStocks and Investing
Fri, June 21, 2024
Thu, June 20, 2024
Wed, June 19, 2024
Tue, June 18, 2024

Matthew Harrison Downgraded (ZNTL) to Hold and Decreased Target to $8 on, Jun 18th, 2024


Published on 2024-10-28 11:59:31 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Downgraded "Zentalis Pharmaceuticals, Inc." (ZNTL) to Hold and Decreased Target from $38 to $8 on, Jun 18th, 2024.

Matthew has made no other calls on ZNTL in the last 4 months.



There is 1 other peer that has a rating on ZNTL. Out of the 1 peers that are also analyzing ZNTL, all agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Robert Driscoll of "Wedbush" Maintained at Hold with Increased Target to $15 on, Wednesday, February 28th, 2024